Publications Search - Abstract View
||HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians.
||Nair M, Prabhakaran D, Narayan KM, Sinha R, Lakshmy R, Devasenapathy N, Daniel CR, Gupta R, George PS, Mathew A, Tandon N, Reddy KS
||Prim Care Diabetes
||AIM: To determine the glycosylated haemoglobin (HbA(1c)) cut-points for diabetes and impaired fasting glucose (IFG) among Asian Indians. METHODS: Participants (n=525) were a random sample selected from the India Health Study. Based on history and fasting plasma glucose (FPG), participants were classified into known diabetes, newly diagnosed diabetes (NDD), impaired fasting glucose (IFG) [ADA and WHO criteria] or normal fasting glucose (NFG). Receiver Operating Characteristic curves were used to identify the optimum sensitivity and specificity for defining HbA(1c) cut-points for NDD and IFG against the FPG criteria. RESULTS: There were 64 participants with a known history of diabetes. Of the remaining 461, IFG was present in 44.7% (ADA) and 18.2% (WHO), and 10.4% were NDD. Mean HbA(1c) were 5.4 (Â±0.04)% for NFG; 5.7 (Â±0.06)% among IFG-ADA, 5.8 (Â±0.09)% among IFG-WHO; 7.5 (Â±0.33)% for NDD and 8.4 (Â±0.32)% for known diabetes. Optimal HbA(1c) cut-point for NDD was 5.8% (sensitivity=75%, specificity=75.5%, AUC=0.819). Cut-point for IFG (ADA) was 5.5% (sensitivity=59.7%, specificity=59.9%, AUC=0.628) and for IFG (WHO) was 5.6% (sensitivity=60.7%, specificity=65.1%, AUC=0.671). CONCLUSION: In this study population from north and south regions of India, the HbA(1c) cut-point that defines NDD (â¥5.8%) was much lower than that proposed by an international expert committee and the American Diabetes Association (â¥6.5%). A cut-point of â¥5.5% or â¥5.6% defined IFG, and was slightly lower than the â¥5.7% for high risk proposed, but accuracy was less than 70%.